• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

In vivo Neutralization of Pro-inflammatory Cytokines During Secondary Streptococcus pneumoniae Infection Post Influenza A Virus Infection

tetano

Editor, Senior Moderator
Front Immunol. 2019 Aug 14;10:1864. doi: 10.3389/fimmu.2019.01864. eCollection 2019.
[h=1]In vivo Neutralization of Pro-inflammatory Cytokines During Secondary Streptococcus pneumoniae Infection Post Influenza A Virus Infection.[/h] Sharma-Chawla N[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Stegemann-Koniszewski S[SUP]2,[/SUP][SUP]3,[/SUP][SUP]4[/SUP], Christen H[SUP]2[/SUP], Boehme JD[SUP]2,[/SUP][SUP]3[/SUP], Kershaw O[SUP]5[/SUP], Schreiber J[SUP]4[/SUP], Guzm?n CA[SUP]6,[/SUP][SUP]7[/SUP], Bruder D[SUP]2,[/SUP][SUP]3[/SUP], Hernandez-Vargas EA[SUP]1[/SUP].
[h=3]Author information[/h] 1 Frankfurt Institute for Advanced Studies, Frankfurt am Main, Germany. 2 Immune Regulation Group, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany. 3 Infection Immunology Group, Institute of Medical Microbiology, Infection Prevention and Control, Health Immunology, Infectiology and Inflammation, Otto-von-Guericke University Magdeburg, Magdeburg, Germany. 4 Experimental Pneumology, University Hospital of Pneumology, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke University Magdeburg, Magdeburg, Germany. 5 Department of Veterinary Medicine, Institute of Veterinary Pathology, Free University Berlin, Berlin, Germany. 6 Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany. 7 Centre for Individualized Infection Medicine (CiiM), Hanover, Germany.

[h=3]Abstract[/h] An overt pro-inflammatory immune response is a key factor contributing to lethal pneumococcal infection in an influenza pre-infected host and represents a potential target for therapeutic intervention. However, there is a paucity of knowledge about the level of contribution of individual cytokines. Based on the predictions of our previous mathematical modeling approach, the potential benefit of IFN-γ- and/or IL-6-specific antibody-mediated cytokine neutralization was explored in C57BL/6 mice infected with the influenza A/PR/8/34 strain, which were subsequently infected with the Streptococcus pneumoniae strain TIGR4 on day 7 post influenza. While single IL-6 neutralization had no effect on respiratory bacterial clearance, single IFN-γ neutralization enhanced local bacterial clearance in the lungs. Concomitant neutralization of IFN-γ and IL-6 significantly reduced the degree of pneumonia as well as bacteremia compared to the control group, indicating a positive effect for the host during secondary bacterial infection. The results of our model-driven experimental study reveal that the predicted therapeutic value of IFN-γ and IL-6 neutralization in secondary pneumococcal infection following influenza infection is tightly dependent on the experimental protocol while at the same time paving the way toward the development of effective immune therapies.


[h=4]KEYWORDS:[/h] IFN-γ neutralization; IL-6 neutralization; Influenza Virus; Streptococcus pneumoniae; co-infection; mathematical modeling

PMID: 31474978 PMCID: PMC6702285 DOI: 10.3389/fimmu.2019.01864
Free full text
 
Back
Top Bottom